InMed Pharmaceuticals Inc. Common Shares (INM) Dividend History

Company News

• InMed Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buying

  The Dow Jones index closed higher by over 450 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. GeoVax Labs The Trade: GeoVax Labs, Inc. (NASDAQ: GOVX) President, CEO David A Dodd acquired a total of 8,729 shares an average price of $2.27. To ...

  Benzinga

  Featured Companies: BENF GOVX
• InMed Reports Second Quarter Fiscal 2023 Financial Results and Provides Business Update

  VANCOUVER, British Columbia, Feb. 17, 2023 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, today announced financial results for the second quarter of fiscal year 2023 which ended December 31, 2022.

  GlobeNewswire Inc.
• Biotech Stock Roundup: CTMX Surges on REGN's Deal, APLS Up on Regulatory Update

  Updates from CTMX and APLS are the key highlights from the biotech sector during the past week.

  Zacks Investment Research

  Featured Companies: APLS CTMX REGN
• Trending Penny Stocks For Your September Watchlist 

  Here's what you need to know about trading penny stocks on September 2nd The post Trending Penny Stocks For Your September Watchlist  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

  PennyStocks